| abstract |
The present invention pertains to the use of a composition comprising a florfenicol ester and a pharmaceutically acceptable solvent wherein the florfenicol ester is selected from the group consisting of florfenicol acetate, florfenicol propionate, florfenicol butyrate, florfenicol pentanoate, florfenicol heptanoate, florfenicol octanoate, florfenicol nanoate, florfenicol decanoate, florfenicol undecanoate, and florfenicol dodecanoate; for the manufacture of a medicament for treating a bacterial infection that is susceptible to florfenicol in a bovine that can be administered as a single injection in an amount sufficient to treat the infection without requiring a second injection |